The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Exchanges
00:00
Introduction
The hosts discuss the significance of the next generation of anti-obesity medications, their impact on various sectors, and the role of social media in increasing awareness. Guests Chris Chibatani and Jason English join to explore the business and investor implications of these drugs, focusing on GLP1s and their wider adoption.
Transcript
Play full episode
